Prognosis
Biden’s Orphaned AstraZeneca Stockpile Grows to 20 Million Doses
- Some experts say U.S. should donate entire AstraZeneca supply
- Company has yet to ask for FDA approval of two-shot vaccine
This article is for subscribers only.
The U.S. stockpile of the controversial AstraZeneca Plc coronavirus vaccine has grown to more than 20 million doses, according to people familiar with the matter, even as the shot looks increasingly unlikely to factor into President Joe Biden’s domestic vaccination campaign.
AstraZeneca has yet to request Food and Drug Administration authorization for the two-dose vaccine, and the company faces safety questions abroad and scrutiny from U.S. regulators who’ve already rebuked it for missteps during clinical trials and partial data releases.